Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M A Powell

Showing results (51-60 of 61) with videos related to

Pageof 7
Sort By:
Gynecologic Oncology|December 22, 2007
Surgical management and adjuvant therapy for patients with uterine clear cell carcinoma: a multi-institutional reviewM Thomas, A Mariani, J D Wright, et al.
European Journal of Gynaecological Oncology|March 25, 2014
The prognostic significance of lymphovascular space invasion in laparoscopic versus abdominal hysterectomy for endometrioid endometrial cancerS B Dewdney, Z Jiao, A A Roma, et al.
British Journal of Cancer|February 24, 2006
Uterine papillary serous and clear cell carcinomas predict for poorer survival compared to grade 3 endometrioid corpus cancersC A Hamilton, M K Cheung, K Osann, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|February 14, 2021
Long-Term Outcomes of Cervical Cancer Patients Treated With Definitive Chemoradiation Following a Complete Metabolic ResponseA J Lin, F Dehdashti, L S Massad, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 2, 2024
Adding immunotherapy to first-line treatment of advanced and metastatic endometrial cancerG Bogani, B J Monk, M A Powell, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|July 25, 2007
A multi-institutional evaluation of factors predictive of toxicity and efficacy of bevacizumab for recurrent ovarian cancerJ D Wright, A A Secord, T M Numnum, et al.
Oncogene|May 26, 2007
Frequent activating FGFR2 mutations in endometrial carcinomas parallel germline mutations associated with craniosynostosis and skeletal dysplasia syndromesP M Pollock, M G Gartside, L C Dejeza, et al.
Ultrasound in Obstetrics & Gynecology : the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology|August 22, 2023
Characterization of adnexal lesions using photoacoustic imaging to improve sonographic O-RADS risk assessmentQ Zhu, H Luo, W D Middleton, et al.
Gynecologic Oncology Reports|June 25, 2021
Radiation therapy for vaginal and perirectal lesions in recurrent ovarian cancerE A Johns, J A Stanley, M D Toboni, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|February 21, 2007
Salvage of isolated vaginal recurrences in women with surgical stage I endometrial cancer: a multiinstitutional experienceW K Huh, J M Straughn, A Mariani, et al.
Pageof 7

Showing results (51-60 of 61) with videos related to

Sort By:
Pageof 7
Gynecologic Oncology|December 22, 2007
Surgical management and adjuvant therapy for patients with uterine clear cell carcinoma: a multi-institutional reviewM Thomas, A Mariani, J D Wright, et al.
European Journal of Gynaecological Oncology|March 25, 2014
The prognostic significance of lymphovascular space invasion in laparoscopic versus abdominal hysterectomy for endometrioid endometrial cancerS B Dewdney, Z Jiao, A A Roma, et al.
British Journal of Cancer|February 24, 2006
Uterine papillary serous and clear cell carcinomas predict for poorer survival compared to grade 3 endometrioid corpus cancersC A Hamilton, M K Cheung, K Osann, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|February 14, 2021
Long-Term Outcomes of Cervical Cancer Patients Treated With Definitive Chemoradiation Following a Complete Metabolic ResponseA J Lin, F Dehdashti, L S Massad, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 2, 2024
Adding immunotherapy to first-line treatment of advanced and metastatic endometrial cancerG Bogani, B J Monk, M A Powell, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|July 25, 2007
A multi-institutional evaluation of factors predictive of toxicity and efficacy of bevacizumab for recurrent ovarian cancerJ D Wright, A A Secord, T M Numnum, et al.
Oncogene|May 26, 2007
Frequent activating FGFR2 mutations in endometrial carcinomas parallel germline mutations associated with craniosynostosis and skeletal dysplasia syndromesP M Pollock, M G Gartside, L C Dejeza, et al.
Ultrasound in Obstetrics & Gynecology : the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology|August 22, 2023
Characterization of adnexal lesions using photoacoustic imaging to improve sonographic O-RADS risk assessmentQ Zhu, H Luo, W D Middleton, et al.
Gynecologic Oncology Reports|June 25, 2021
Radiation therapy for vaginal and perirectal lesions in recurrent ovarian cancerE A Johns, J A Stanley, M D Toboni, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|February 21, 2007
Salvage of isolated vaginal recurrences in women with surgical stage I endometrial cancer: a multiinstitutional experienceW K Huh, J M Straughn, A Mariani, et al.
Pageof 7